Cargando…
Blood-Derived Systemic Inflammation Markers and Risk of Nodal Failure in Stage Ia Non-Small Cell Lung Cancer: A Multicentric Study
Background: Unexpected spread to regional lymph nodes can be found in up to 10% of patients with early stage non-small cell lung cancer (NSCLC), thereby affecting both prognosis and treatment. Given the known relation between systemic inflammation and tumor progression, we sought to evaluate whether...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10419646/ https://www.ncbi.nlm.nih.gov/pubmed/37568316 http://dx.doi.org/10.3390/jcm12154912 |
_version_ | 1785088575599017984 |
---|---|
author | Tacconi, Federico Mangiameli, Giuseppe Voulaz, Emanuele Patirelis, Alexandro Carlea, Federica Rocca, Eleonora La Tamburrini, Alessandro Vanni, Gianluca Ambrogi, Vincenzo |
author_facet | Tacconi, Federico Mangiameli, Giuseppe Voulaz, Emanuele Patirelis, Alexandro Carlea, Federica Rocca, Eleonora La Tamburrini, Alessandro Vanni, Gianluca Ambrogi, Vincenzo |
author_sort | Tacconi, Federico |
collection | PubMed |
description | Background: Unexpected spread to regional lymph nodes can be found in up to 10% of patients with early stage non-small cell lung cancer (NSCLC), thereby affecting both prognosis and treatment. Given the known relation between systemic inflammation and tumor progression, we sought to evaluate whether blood-derived systemic inflammation markers might help to the predict nodal outcome in patients with stage Ia NSCLC. Methods: Preoperative levels of neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and systemic inflammation score (SII, platelets × NLR) were collected from 368 patients who underwent curative lung resection for NSCLC. After categorization, inflammatory markers were subjected to logistic regression and time-event analysis in order to find associations with occult nodal spread and postoperative nodal recurrence. Results: No inflammation marker was associated with the risk of occult nodal spread. SII showed a marginal effect on early nodal recurrence at a quasi-significant level (p = 0.065). However, patients with T1c tumors and elevated PLR and/or SII had significantly shorter times to nodal recurrence compared to T1a/T1b patients (p = 0.001), while patients with T1c and normal PLR/SII did not (p = 0.128). Conclusions: blood-derived inflammation markers had no value in the preoperative prediction of nodal status. Nevertheless, our results might suggest a modulating effect of platelet-derived inflammation markers on nodal progression after the resection of tumors larger than 2 cm. |
format | Online Article Text |
id | pubmed-10419646 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-104196462023-08-12 Blood-Derived Systemic Inflammation Markers and Risk of Nodal Failure in Stage Ia Non-Small Cell Lung Cancer: A Multicentric Study Tacconi, Federico Mangiameli, Giuseppe Voulaz, Emanuele Patirelis, Alexandro Carlea, Federica Rocca, Eleonora La Tamburrini, Alessandro Vanni, Gianluca Ambrogi, Vincenzo J Clin Med Article Background: Unexpected spread to regional lymph nodes can be found in up to 10% of patients with early stage non-small cell lung cancer (NSCLC), thereby affecting both prognosis and treatment. Given the known relation between systemic inflammation and tumor progression, we sought to evaluate whether blood-derived systemic inflammation markers might help to the predict nodal outcome in patients with stage Ia NSCLC. Methods: Preoperative levels of neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and systemic inflammation score (SII, platelets × NLR) were collected from 368 patients who underwent curative lung resection for NSCLC. After categorization, inflammatory markers were subjected to logistic regression and time-event analysis in order to find associations with occult nodal spread and postoperative nodal recurrence. Results: No inflammation marker was associated with the risk of occult nodal spread. SII showed a marginal effect on early nodal recurrence at a quasi-significant level (p = 0.065). However, patients with T1c tumors and elevated PLR and/or SII had significantly shorter times to nodal recurrence compared to T1a/T1b patients (p = 0.001), while patients with T1c and normal PLR/SII did not (p = 0.128). Conclusions: blood-derived inflammation markers had no value in the preoperative prediction of nodal status. Nevertheless, our results might suggest a modulating effect of platelet-derived inflammation markers on nodal progression after the resection of tumors larger than 2 cm. MDPI 2023-07-26 /pmc/articles/PMC10419646/ /pubmed/37568316 http://dx.doi.org/10.3390/jcm12154912 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Tacconi, Federico Mangiameli, Giuseppe Voulaz, Emanuele Patirelis, Alexandro Carlea, Federica Rocca, Eleonora La Tamburrini, Alessandro Vanni, Gianluca Ambrogi, Vincenzo Blood-Derived Systemic Inflammation Markers and Risk of Nodal Failure in Stage Ia Non-Small Cell Lung Cancer: A Multicentric Study |
title | Blood-Derived Systemic Inflammation Markers and Risk of Nodal Failure in Stage Ia Non-Small Cell Lung Cancer: A Multicentric Study |
title_full | Blood-Derived Systemic Inflammation Markers and Risk of Nodal Failure in Stage Ia Non-Small Cell Lung Cancer: A Multicentric Study |
title_fullStr | Blood-Derived Systemic Inflammation Markers and Risk of Nodal Failure in Stage Ia Non-Small Cell Lung Cancer: A Multicentric Study |
title_full_unstemmed | Blood-Derived Systemic Inflammation Markers and Risk of Nodal Failure in Stage Ia Non-Small Cell Lung Cancer: A Multicentric Study |
title_short | Blood-Derived Systemic Inflammation Markers and Risk of Nodal Failure in Stage Ia Non-Small Cell Lung Cancer: A Multicentric Study |
title_sort | blood-derived systemic inflammation markers and risk of nodal failure in stage ia non-small cell lung cancer: a multicentric study |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10419646/ https://www.ncbi.nlm.nih.gov/pubmed/37568316 http://dx.doi.org/10.3390/jcm12154912 |
work_keys_str_mv | AT tacconifederico bloodderivedsystemicinflammationmarkersandriskofnodalfailureinstageianonsmallcelllungcanceramulticentricstudy AT mangiameligiuseppe bloodderivedsystemicinflammationmarkersandriskofnodalfailureinstageianonsmallcelllungcanceramulticentricstudy AT voulazemanuele bloodderivedsystemicinflammationmarkersandriskofnodalfailureinstageianonsmallcelllungcanceramulticentricstudy AT patirelisalexandro bloodderivedsystemicinflammationmarkersandriskofnodalfailureinstageianonsmallcelllungcanceramulticentricstudy AT carleafederica bloodderivedsystemicinflammationmarkersandriskofnodalfailureinstageianonsmallcelllungcanceramulticentricstudy AT roccaeleonorala bloodderivedsystemicinflammationmarkersandriskofnodalfailureinstageianonsmallcelllungcanceramulticentricstudy AT tamburrinialessandro bloodderivedsystemicinflammationmarkersandriskofnodalfailureinstageianonsmallcelllungcanceramulticentricstudy AT vannigianluca bloodderivedsystemicinflammationmarkersandriskofnodalfailureinstageianonsmallcelllungcanceramulticentricstudy AT ambrogivincenzo bloodderivedsystemicinflammationmarkersandriskofnodalfailureinstageianonsmallcelllungcanceramulticentricstudy |